PK
Pradeep Kumar Sahal
About Pradeep Kumar Sahal
Data last updated:
Pradeep Kumar Sahal is a Director at Supravitz Lifesciences Private Limited (since 2017), Director at Nuramed Pharmaceuticals Private Limited (since 2022) and Designated Partner at Nuramed Lifesciences Llp (since 2022). The companies operate in Healthcare, Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹21.82 Cr; the largest is Supravitz Lifesciences Private Limited at ₹16.30 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Aug 2017 | 2017 | ₹16.30 Cr (FY 2025) | Active | |
| Director | 14 Oct 2022 | 2022 | ₹5.52 Cr (FY 2025) | Active | |
| Designated Partner | 29 May 2022 | 2022 | Active |
Board colleagues of Pradeep Kumar Sahal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dipak Kumar Tibrewal | 07292544 | Supravitz Lifesciences Private Limited | Director |
| Rajesh Kumar Agarwal | 02156678 | Supravitz Lifesciences Private Limited | Director |
| Nitin Rammilan Tiwari | 10004065 | Nuramed Pharmaceuticals Private Limited , Nuramed Lifesciences Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Kumar Sahal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Kumar Sahal
Pradeep Kumar Sahal currently holds 3 directorships: Supravitz Lifesciences Private Limited (Director, since 25 Aug 2017, revenue ₹16.30 Cr (FY 2025)); Nuramed Pharmaceuticals Private Limited (Director, since 14 Oct 2022, revenue ₹5.52 Cr (FY 2025)); Nuramed Lifesciences Llp (Designated Partner, since 29 May 2022).
Pradeep Kumar Sahal was first appointed on 25 Aug 2017 as Director at Supravitz Lifesciences Private Limited. The most recent appointment on record is 14 Oct 2022 at Nuramed Pharmaceuticals Private Limited.
The 2 current companies of Pradeep Kumar Sahal that report revenue have a combined latest revenue of ₹21.82 Cr: Supravitz Lifesciences Private Limited ₹16.30 Cr (FY 2025); Nuramed Pharmaceuticals Private Limited ₹5.52 Cr (FY 2025).
The current boards of Pradeep Kumar Sahal's companies include Dipak Kumar Tibrewal (Supravitz Lifesciences Private Limited), Rajesh Kumar Agarwal (Supravitz Lifesciences Private Limited), Nitin Rammilan Tiwari (Nuramed Pharmaceuticals Private Limited).